Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05177042
Title Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arvinas Androgen Receptor, Inc.

prostate adenocarcinoma


Abiraterone + ARV-110

Age Groups: senior | adult
Covered Countries USA | FRA | CAN

No variant requirements are available.